Corcept Therapeutics Inc logo

CORT

Corcept Therapeutics Inc

$32.04

Earnings Summary

Revenue
$146.81Mn
Net Profits
$27.76Mn
Net Profit Margins
18.91%
PE Ratio
29.16

Highlights

Revenue:

Corcept Therapeutics Inc’s revenue jumped 38.95% since last year same period to $146.81Mn in the Q1 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated 8.42% jump in its revenue since last 3-months.

Net Profits:

Corcept Therapeutics Inc’s net profit jumped 74.83% since last year same period to $27.76Mn in the Q1 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated -11.46% fall in its net profits since last 3-months.

Net Profit Margins:

Corcept Therapeutics Inc’s net profit margin jumped 25.82% since last year same period to 18.91% in the Q1 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated -18.34% fall in its net profit margins since last 3-months.

PE Ratio:

Corcept Therapeutics Inc’s price-to-earnings ratio after this Q1 2024 earnings stands at 29.16.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Corcept Therapeutics Inc post its latest quarter earnings

EPS Estimate Current Quarter
0.23
EPS Estimate Current Year
0.23

Highlights

EPS Estimate Current Quarter:

Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.23 - a 4.55% jump from last quarter’s estimates.

EPS Estimate Current Year:

Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.23.

Key Ratios

Key ratios of the Corcept Therapeutics Inc post its Q1 2024 earnings

Earning Per Share (EPS)
0.25
Return on Assets (ROA)
0.12
Return on Equity (ROE)
0.22

Highlights

Earning Per Share (EPS):

Corcept Therapeutics Inc’s earning per share (EPS) jumped 78.57% since last year same period to 0.25 in the Q1 2024. This indicates that the Corcept Therapeutics Inc has generated 78.57% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Corcept Therapeutics Inc’s return on assets (ROA) stands at 0.12.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Corcept Therapeutics Inc’s return on equity (ROE) stands at 0.22.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-01
0.22
0.25
13.64%